MedTrace Logo

Malignant Progression of Anal Intra-epithelial Neoplasia in a Cohort of Patients

NCT01877135 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2015-03-05

No results posted yet for this study

Summary

Evaluation of the 3-years anal carcinoma (AC) incidence in patient with anal AIN3 lesions, and factors associated with this AC. A retrospective cohort study will be conducted (2000-2013) followed by a prospective cohort study (starting in 2013) with new diagnoses of anal AIN3 lesion. The main outcome is histology proven AC. The 3-years incidence rate of AC will be calculated. Factors associated with AC will be estimated using a multivariate Cox regression model.

Conditions

  • Anal AIN3
  • Anal Carcinoma

Sponsors & Collaborators

  • Société Nationale Française de Gastroentérologie

    collaborator OTHER

  • French Society of Coloproctology

    lead OTHER

Principal Investigators

  • Laurent Abramowitz, MD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2016-06-30
Completion
2019-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01877135 on ClinicalTrials.gov